Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -108,327 | -126,710 | -52,870 | -23,009 | -4,071 |
| Depreciation Amortization | 29,951 | 27,102 | 2,398 | 576 | 891 |
| Income taxes - deferred | 857 | 138 | -214 | 18 | -177 |
| Accounts receivable | -6,745 | -12,852 | -893 | 10 | 73 |
| Accounts payable and accrued liabilities | -10,720 | -3,932 | 4,441 | -184 | -607 |
| Other Working Capital | -29,994 | -10,985 | -57 | 882 | 284 |
| Other Operating Activity | 69,512 | 72,340 | 12,839 | 2,348 | 4,062 |
| Operating Cash Flow | $-55,466 | $-54,899 | $-34,356 | $-19,359 | $455 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -442 | -754 | -155 | 34 | 90 |
| Net Acquisitions | N/A | N/A | 25,290 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 192 | 0 | 36,582 |
| Investing Cash Flow | $-442 | $-754 | $25,327 | $34 | $36,672 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 70,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 354 | 109 | 21,481 | 5,508 | 509 |
| Dividend Paid | N/A | N/A | -15,000 | N/A | N/A |
| Other Financing Activity | -22,966 | 0 | -30,000 | 0 | 0 |
| Financing Cash Flow | $47,388 | $109 | $-23,519 | $5,508 | $509 |
| Exchange Rate Effect | -1,756 | 2,047 | -349 | -267 | -249 |
| Beginning Cash Position | 55,430 | 108,927 | 141,824 | 155,908 | 118,521 |
| End Cash Position | 45,154 | 55,430 | 108,927 | 141,824 | 155,908 |
| Net Cash Flow | $-10,276 | $-53,497 | $-32,897 | $-14,084 | $37,387 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,466 | -54,899 | -34,356 | -19,359 | 455 |
| Capital Expenditure | -442 | -754 | -155 | -9 | -25 |
| Free Cash Flow | -55,908 | -55,653 | -34,511 | -19,368 | 430 |